Glyphosate: A timeline of the controversial weedkiller’s history and legal troubles

Credit: Josh Edelson/AFP/Getty Images
Credit: Josh Edelson/AFP/Getty Images

How did we get here? The timeline below includes some of the more significant events, starting with Monsanto’s founding.

Roundup History Timeline

1901: The Monsanto Chemical Works company was founded.

Follow the latest news and policy debates on sustainable agriculture, biomedicine, and other ‘disruptive’ innovations. Subscribe to our newsletter.

1970: Monsanto scientist John Franz discovered glyphosate could be used as an herbicide and patented the discovery.

1974: Monsanto brought glyphosate to market under the trade name Roundup.

1985: The Environmental Protection Agency classified glyphosate as a Group C Carcinogen, meaning it has “suggestive evidence of carcinogenic potential.”

1991: EPA changed carcinogenic classification to Group E, meaning “evidence of non-carcinogenicity for humans.”

1996: Asgrow introduced Roundup Ready soybeans to the market, which have been genetically modified to resist the effects of Roundup.

2000: Monsanto’s glyphosate went off patent in 2000. Several product variants entered the market.

Jan. 28, 2016: San Francisco groundskeeper Dewayne “Lee” Johnson filed a lawsuit in California state court against Monsanto alleging his exposure to Monsanto’s Roundup weed killer and its active ingredient, glyphosate, caused him to develop Non-Hodgkin lymphoma, with which Johnson was first diagnosed in August 2014.

Sept. 14, 2016Bayer and Monsanto announce a definitive merger agreement under which Bayer will acquire Monsanto.

June 2, 2017: Alva and Alberta Pilliod sue Monsanto over Roundup in Alameda County Superior Court stating it caused both of their non-Hodgkin lymphomas. Alberta Pilliod was diagnosed with Non-Hodgkin lymphoma brain cancer in 2015 and Alva Pilliod was diagnosed in 2011.

June 7, 2018Bayer completed the acquisition of Monsanto for $63 billion.

May 13, 2019Jury sides with Pilliods and orders Monsanto to pay slightly over $2 billion ($1 billion to each) in punitive and a combined $55 million in compensatory damages.

June 24, 2020: Bayer announced a settlement between $8.8 billion and $9.6 billion to address close to 100,000 existing claims that exposure to Roundup caused their Non-Hodgkin lymphoma. Another $1.25 billion was set aside to address claims by potential future plaintiffs, which would have included a maximum of $150 million in attorney fees.

May 26, 2021: Chhabria rejects Monsanto/Bayer’s proposal to deal with future cases.

July 29, 2021Bayer announces it will remove glyphosate from the U.S. residential lawn and garden marketplace, effective January 2023.

This is an excerpt. Read the original post here

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}

Related Articles

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Infographic: Global regulatory and health research agencies on whether glyphosate causes cancer

Does glyphosate—the world's most heavily-used herbicide—pose serious harm to humans? Is it carcinogenic? Those issues are of both legal and ...

Most Popular

ChatGPT-Image-Mar-10-2026-01_39_01-PM
Viewpoint—“Miracle molecule” debunked: Why acemannan supplements don’t work
ChatGPT-Image-Jun-25-2026-12_23_17-PM
No, Bill Gates did not secretly engineer ticks to promote veganism
ChatGPT-Image-Jun-19-2026-04_11_20-PM
Daubert for Dummies—Scientific Reliability in U.S. Courts: Daubert, Rule 702, and Made-for-Litigation Evidence
ChatGPT-Image-Jun-17-2026-10_52_43-AM
Anguished parents, doctors in tears: Utah’s long measles outbreak takes a toll
Screenshot-2026-06-22-at-9.04.46-PM
Kennedy's nutrition prescription for medical schools: Real problem, bad cure
ChatGPT-Image-Jun-23-2026-03_12_23-PM
Is cellular reprogramming junk science? Nearly 20 patients are getting eye injections in the first FDA-cleared cellular trial
Screenshot-2026-06-15-at-1.55.27-PM
America's trust in Trump-Kennedy's CDC health recommendations is plunging
ChatGPT-Image-Jun-15-2026-11_51_00-AM-4
Viewpoint: As the International Association for Research on Cancer loses influence, activists and trial lawyers scramble to protect a lucrative playbook

Sorry. No data so far.

glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.